Buradasınız

Anasayfa » Content

LÖKOSİTOZLA SEYREDEN TÜYLÜ HÜCRELİ LÖSEMİ : OLGU SUNUMU

HAIRY CELL LEUKEMIAWITH LEUKOCYTOSIS: CASE REPORT

Journal Name:

  • İstanbul Tıp Fakültesi Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Hairy cell leukemia is a rare chronic lymphoproliferative disorder. The patients usually present with pancytopenia and splenomegaly with few circulating neoplastic cells. Occasional patients have elevated leukocyte counts as a result of circulating hairy cells. Here, we report a patient of hairy cell leukemia presenting with leukocytosis.
Bookmark/Search this post with
Abstract (Original Language): 
Tüylü hücreli lösemi nadir görülen kronik seyirli bir lenfoproliferatif hastal›kt›r. Ço¤u kez hastalarda splenomegali ve pansitopeni bulunur, formülde az say›da tüylü lösemi hücresi görülebilir. Baz› hastalarda periferik kanda tüylü lösemi hücrelerinin art›fl›na ba¤l› olarak yüksek lökosit say›s› saptanabilir. Bu yaz›da bafllang›çta lökositozla kendini gösteren bir tüylü hücreli lösemi olgusu bildirilmektedir.
FULL TEXT (PDF): 
PDF icon arastirmax-lokositozla-seyreden-tuylu-hucreli-losemi-olgu-sunumu.pdf
  • 1
19-21
  • Turkish

REFERENCES

References: 

1. Adley BP, Sun X, Shaw JM, Variakojis D. Hairy cell leukemia
with marked lymphocytosis. Arch Pathol Lab Med 2003;
127:253-254.
2. Allsup DJ, Cawley JC. The diagnosis and treatment of hairy cell
leukemia Blood Rev 2002; 16:255-262.
3. Dedic K, Zak P. Bone marrow fibrosis during therapy of hairy
cell leukemia. Cesk Patol 2004; 40:22-24.
4. Else M, Ruchlemer R, Osuji N, Del Giudice I, Matutes E, Woodman
A et al. Long remissions in hairy cell leukemia with purine
analogs. Cancer 2005; 104:2442-2448.
5. Gupta K, Jasmina A, Malhotre P, Varma N, Vaiphei K, Vohra H
et al. Hairy cell leukemia-variant: a case report. Indian J Pathol
Microbiol 2005; 48:387-389.
6. Johnston JB. Hairy cell leukemia. Greer JP, Foerster J, Lukens JN
et al (ed). Wintrobe’s Clinical Hematology. Philadelphia PA: Lippincott
Williams&Wilkins; 2004:2465-2484.
7. Quaresima M, Iacobelli S, Tempera S, Frattarelli N, Bizzoni L,
Anaclerico B et al. Hairy cell leukemia: Prognostic factors and
treatment. Clin Ter 2006; 157:105-109.
8. Robak T. Current treatment options in hairy cell leukemia and hairy
cell leukemia variant. Cancer Treat Rev 2006; 32:365-376.
9. Robak T, Jamroziak K, Gora-Tybor J, Blonski JZ, Kasznicki M,
Dwilewicz-Trojaczek J et al. Cladribine in a daily versus weekly
Schedule for untreated active hairy cell leukemia. Blood 2007;
109:3672-3675.
10. Shibayama H, Machii T, Yamaguchi M, Tokumine Y, Kitani T.
Early age onset of hairy cell leukemia presenting with leukocytosis.
Int J Hematol 1996; 64:287-290.
11. Zinzani PL, Tani M, Marchi E, Stefoni V, Alinari L, Musuraca G
et al. Long term follow-up of front-line treatment of hairy cell leukemia
with 2-chlorodeoxyadenosine. Haematologica 2004;
89:309-313.

Thank you for copying data from http://www.arastirmax.com